Edith Sim BSc(Edinb), MA, DPhil (Oxon) has served as Head of the Department of Pharmacology at the University of Oxford and served as Faculty Dean at The University of Kingston, UK. Her studies in molecular immunology and membrane biochemistry resulted in an interest in pharmacogenetics and the possibilities of personalized. She has studied the pharmacogenetically controlled acetylation of drugs and xenobiotics by the enzyme arylamine N-acetyltransferase. and She was given a lifetime achievement award from the Arylamine N-acetyltransferases workshop group in 2015, particularly for her work in determining the enzyme’s structure and the mechanism of action via a catalytic triad. She was also awarded, in 2012, the John Vane medal of the British Pharmacological Society for her work on these enzymes. She has published over 200 original papers and reviews and has explored the arylamine N-acetyltransferases in cancer where the human NAT1 enzyme has been demonstrated to be overexpressed in male and female breast cancer. The human arylamine N-acetyltransferase isoenzyme NAT2 in humans catalyses the inactivation of isoniazid, an anti-tubercular. She has explored the version of arylamine N-acetyltransferase in mycobacteria and has identified that the nat enzyme along with other enzymes encoded in the same cluster, particularly HsaD, are potential targets for anti-tubercular therapy. She has also worked on enzymes which generate the arylamine substrates of nat, specifically the azoreductases. These studies have relied on an approach across chemistry and biology utilizing physical techniques as appropriate. She has collaborated widely in an international context and has also been involved in drug development with spin out companies. She is an Emeritus professor at both Oxford University and Kingston University and is an Emeritus Fellow of St Peter’s College, Oxford. Her co-edited book on the Arylamine N-acetyltransferases (with her former student Nicola Laurieri) is published in May 2018.
Professor McGloughlin BE, MEngSc (UCD), PhD TCD, Ireland. Following a long career at the University of Limerick (UL), in 2014 he joined Khalifa University of Science Technology in Abu Dhabi, UAE as Chair of Biomedical Engineering. His research interests include medical device technologies, cardiovascular biomechanics and tissue engineering. Professor McGloughlin was the Founding Director of the Centre for Applied Biomedical Engineering Research at UL and has published more than 150 refereed journal and conference papers in biomedical engineering as well as 2 books and 7 book chapters. He is a named co-inventor on 7 Patent Applications which are at various stages of the patenting process. He is a Fellow of the Royal Academy of Medicine in Ireland (Bioengineering Section), a Fellow of Engineers Ireland and a member of the Irish Medical Devices Association (IMDA). He was a member of the Executive Committee of the ASME Bioengineering Division (2010-2013) and is a member of the World Council for Biomechanics and the ESB.
Pankaj Vadgama has degrees in Medicine and Chemistry and is a Chemical Pathologist with an interest in Point of Care Testing, especially for diabetes and shock states. He was Professor of Clinical Biochemistry at the University of Manchester, and is currently at Queen Mary, University of London in the School of Engineering and Materials Science. His general research interest is in biomaterial surface interactions and the design of electrochemical biosensors for continuous monitoring. He has worked on tissue monitoring of oxygen, glucose and lactate using membrane modified and recess tip devices for enhanced biocompatibility. Previously has also worked on sensor integration with microfluidics, spider silk as implant materials and membranes for bioreactors.
His general research interest is in biomaterial surface interactions and the design of electrochemical biosensors for continuous monitoring. He has worked on tissue monitoring of oxygen, glucose and lactate using membrane modified and recess tip devices for enhanced biocompatibility. Previously has also worked on sensor integration with microfluidics, spider silk as implant materials and membranes for bioreactors.
Dr. Shmuel Einav, Professor of Biomedical Engineering, is a world-distinguished expert in the cardiovascular circulatory system and the field of biomedical engineering. He is best known for his studies on blood flow through heart valves, coronary circulation, blood-tissue interaction, and flow and turbulent characteristics in occluded arteries. The focus of his research is the role of Hemodynamics in the initiation of atherosclerosis, the dynamics of cardiovascular flows, and the influence of flow and the associated shear stress on vascular endothelial biology. In recognition of his significant achievements and important contributions to science, biomedicine and technology, he has been elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), Fellow of the Biomedical Engineering Society (BMES), Fellow of the International Federation for Medical and Biological Engineering (IFMBE) and a Fellow of the American Society of Mechanical Engineers (ASME).
Founder Partner and CEO, NeoBioMed Services, providing consultancy and services related to regulatory affairs, technology transfer and entry India issues for APIs, pharmaceuticals, biopharmaceuticals, medical devices including bioimplants, regenerative medicine and tissue engineering including stem cell research and application, designing GMP, GLP, containment facilities and other related commercial activities and businesses. As Advisor/Director of a number of academic/ industrial organizations, support is provided for promotion and application of biological sciences including biomedical, bio-agri, bio-industrial, bio-ventures, bio-defence and allied services including policy matters. He also worked as an Adviser, HOD International Relations, Medical Biotechnology and Infrastructure Development, Department of Biotechnology, Ministry of Science and Technology, Govt. of India.
Desineni “Subbaram” Naidu received MTech and PhD degrees in Electrical Engineering (with specialization in Control Systems Engineering), from Indian Institute of Technology (IIT), Kharagpur. Dr. Naidu taught, visited and/or conducted research at IIT; as National Research Council (NRC) Senior Research Associate at Guidance and Control Division at NASA Langley Research Center, Hampton, VA; Old Domain University, Norfolk, VA; as Professor, Associate Dean and Director, School of Engineering at Idaho State University and Measurement and Control Engineering Research Center, Pocatello, Idaho; as National Research Council (NRC) Senior Research Associate at Center of Excellence in Advanced Flight Research at United States (US) Air Force Research Laboratory, Wright Patterson Air Force Base (WPAFB), Ohio; as Visiting Research Fellow at Center of Excellence for Ships and Ocean Structures at Norwegian University of Science and Technology, Trondheim, Norway; as Academic Guest at Measurement and Control Laboratory at Swiss Federal Institute of Technology, Zurich, Switzerland; as Visiting Professor at Nantong University, Nanton, China; Visiting Research Professor at the University of Western Australia in Perth, Center for Industrial and Applied Mathematics at the University of South Australia in Adelaide; Jiangsu College of Information Technology, Jiangsu, China; as Visiting Professor at the Center for Applied and Interdisciplinary Mathematics at East China Normal University, Shanghai, China; as Visiting Professor at the Institute of Systems Science, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China; Shanghai Jiao-Tong University, Shanghai, China and as Satish Dhawan Endowed Visiting Professor at Indian Inst. of Science (IISc), Bengaluru, India. Since August 2014, Professor Naidu has been with University of Minnesota Duluth as Minnesota Power Jack Rowe Endowed Chair. Professor Naidu received twice the Senior National Research Council (NRC) Associateship award from the US National Academy of Sciences (NAS), and is an elected (Life) Fellow of the Institute of Electrical and Electronic Engineers (IEEE) and an elected Fellow of the World Innovation Foundation, UK. Professor Naidu has over 200 journal and conference publications including 8 books. He has been on the editorial boards of several journals including the IEEE Transactions on Automatic Control and Optimal Control: Applications and Methods (Wiley). More details at http://www.d.umn.edu/~dsnaidu/
Peter Farrell is the founder and chairman of the board of ResMed and has been chairman and a director since its inception in June 1989. Dr. Farrell also served as chief executive officer from July 1990 until December 2007, and from February 2011 until March 2013. Dr. Farrell served as executive chairman of the board from December 2007 until February 2011, and from March 2013 through December 2013. Since January 1, 2014, he has been a non-officer employee of ResMed. From July 1984 to June 1989, Dr. Farrell served as vice president, research and development at various subsidiaries of Baxter International, Inc., and from August 1985 to June 1989, he also served as managing director of the Baxter Center for Medical Research Pty Ltd., a Baxter subsidiary. From January 1978 to December 1989, he was foundation director of the Graduate School for Biomedical Engineering at the University of New South Wales, where he currently serves as a visiting professor and as chairman of the UNSW Centre for Innovation and Entrepreneurship. He also serves on the Visiting Committee of the Health Sciences & Technology Program at the Massachusetts Institute of Technology and on the MIT Dean of Engineering’s Advisory Council. Dr. Farrell also serves as independent board chairman at Arcturus Therapeutics Ltd (NASDAQ: ARCT), an RNA therapeutics company, and on two faculty advisory boards at the University of California, San Diego: the Rady Business School and the Jacobs Engineering School. He holds a B.E. in chemical engineering with honors from the University of Sydney, an S.M. in chemical engineering from the Massachusetts Institute of Technology, a Ph.D. in chemical engineering and bioengineering from the University of Washington, Seattle and a D.Sc. from the University of New South Wales for research contributions in the field of treatment with the artificial kidney. From 2005 through 2018, Dr. Farrell was a director of NuVasive, Inc., a NASDAQ-listed company which develops and markets products for the surgical treatment of spine disorders. From 2007 through 2014, he was the non-executive chairman of the board of QRx Pharma, a specialty pharmaceutical company. Dr. Farrell is a fellow or honorary fellow of several professional bodies, including being a member of the National Academy of Engineering, to which he was elected in 2012. Dr. Farrell was named 1998 San Diego Entrepreneur of the Year for Health Sciences, Australian Entrepreneur of the Year in 2001 and US National Entrepreneur of the Year for Health Sciences in 2005. Dr. Farrell joined the Executive Council of the Division of Sleep Medicine at Harvard Medical School in 1998, served as vice chairman from 2000 until 2010 when he became chairman; he served in that capacity until May 2013. In 2012, he joined the board of trustees of the Scripps Research Institute. Dr. Farrell’s son, Michael Farrell, is ResMed’s chief executive officer and one of its directors. Dr. Farrell’s role as our founder and chief executive officer for over 20 years provides him with a unique and deep understanding of our operations, technology and industry. In addition, his background reflects significant executive experience with other publicly-held medical technology companies and public company governance experience and training. This experience and training includes more than seven years of experience on the nominating and governance committee and one year of experience on the compensation committee of NuVasive, as well as coursework specific to corporate governance from the Harvard Business School.
Pat leads PPC initiatives, including its work on federal healthcare transformation, advocating authentic patient and family engagement across all healthcare settings, promotion of co-design and co-production approaches, and PPC organizational development activities. Leading national and not-for-profit patient and family initiatives locally and nationally, including integration of Person and Family Engagement in hospital, ambulatory care, post-acute care, ESRD facilities, nursing homes, and health systems. Serve as the Patient and Family Engagement Director on a PCORI Award focused on “Patients Improving Research in Diagnosis” with the Society to Improve Diagnosis in Medicine. Prior to joining PPC, Pat was the Executive Director of the federal Quality Innovation Network-Quality Improvement Organization for Medicare in three states and prior to that served as the Senior Vice President of the Illinois Hospital Association where she developed and directed the mulit-state COMPdata information system, Quality Care Institute, and served as the quality liaison with providers and government agencies. Pat serves on several state and national government and professional organization boards and committees. A frequent presenter and speaker at national and local community-based organizations, hospitals, healthcare systems, and business coalition seminars and meetings. Key liaison with various local, state, and national agencies and organizations. Pat is a volunteer with Rotary International and has worked in over a dozen developing countries on strategic health initiatives.
Prof. Abraham Reznick completed his doctorate in molecular biophysics at the Florida State University in Tallahassee Florida, USA in 1974. He continued his post-doctorate work in the Department of Biology of the Technion-Israel Institute of Technology in Haifa Israel where he worked on post-translational modifications of proteins in aging tissues in the laboratory of Prof David Gershon. In the mid eighties he joined the Faculty of Medicine of the Technion where he established "The Laboratory of Biological Oxidations and Muscle Aging". There he developed the immobilization system of aging animals as a model for sarcopenia studies in aging. This led to molecular studies of muscle breakdown involving the signal transduction pathway of NF-kB and to the discovery of the aberrant activation of NF-kB by peroxynitrite. In addition, he also has studied in the last 20 years the oxidative damage caused by cigarette smoke where, among others, he developed a new assay for oxidation of proteins and the Thermochemiluminescence (TCL) assay for biological oxidations. In the mid 90s Prof Reznick served as Secretary General of the Israeli Gerontological Society. In addition, Prof Reznick has been a member of the International and American Free Radical Societies and served as President of the Israeli Oxygen and Free Radical Society in the years 2005-2007. In 2003 he became an Associate Prof of medical sciences in the Faculty of Medicine of the Technion. He is a recipient of the Max Prochovnik Israel Gerontology Award (1984), Hershel Rich Technion Innovation Award (1998) and the Johnson & Johnson Research Award (2005). In 2010 Prof Reznick became the Chairman of the Department of Anatomy and Cell Biology at the Faculty of Medicine of the Technion until his retirement in 2013. Finally, Prof Reznick has published about 155 scientific publications in Pubmed by 2017.
Dr. Leona W. Ayers, MD, Academy Professor is an academic pathologist in the Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA. Board Certified in Clinical and Anatomic Pathology, she has a Medical Staff designation of physician scholar at the Wexner Medical Center and The James Cancer Hospital and Solove Research Institute. Her research interest is in pathophysiology of infectious diseases with focus on virus related malignancy. For the last 23 years she has been funded by grants from USA National Cancer Institute (NCI/NIH). As Principle Investigator (PI) of the NCI MR AIDS and Cancer Specimen Resource, she organized the Sub-Saharan Africa Lymphoma Consortium (SSALC) with pathologist participants from East Africa (Uganda, Kenya), West Africa (Nigeria), South Africa (Johannesburg, Cape Town) and Europe (London). Dr. Ayers also served as a leader in the first NCI workshop in India on Research Methodologies for the study of HIV/AIDS associated malignancies. She collaborates with the NCI funded EMBLEM program in East Africa. Her current research interest centers on the pathophysiology of KSHV (HHV8) in Kaposi ’s sarcoma and the implications for new therapies. Dr. Ayers has published with colleagues numerous journal articles, book chapters, abstracts and posters and given numerous invited presentations nationally and internationally. She is a member of The Ohio State University Comprehensive Cancer Center (OSU-CCC).
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA and he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University(CSU), Irvine, California, USA. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic–scientific–research institutes around the world.
Ramesh R. Galigekere received B.E. in Electronics & Communications Engineering from Mysore University, M.Sc. (Engg.) by Research, from the Department of Electrical Engineering, Indian Institute of Science, Bangalore, India, and Ph.D. in Electrical & Computer Engineering from Concordia University, Montreal, Canada, in 1997. Subsequently, he held Research Positions at various labs in Canada including the Imaging Research Laboratories of the Robarts Research Institute (RRI), and the Neurovascular Research Laboratory at the School of Kinesiology, University of Western Ontario (UWO, both in London, Ontario). He worked briefly as a Guest Scientist at the Medical Engineering Group, Siemens AG, Erlangen, Germany, and served as an Adjunct Professor at the Dept. of Elec. Engg., UWO, Canada. Currently, Dr. Galigekere is a Professor at the Department of Biomedical Engineering (of which he was the Chairman until May 2018), Manipal Institute of Technology, Manipal University, Manipal, India. He has published in reputed international journals and conferences, and has been serving as a reviewer for many. Two of his invention-disclosures (with co-inventors) were awarded by Intellectual Ventures, and subsequently awarded US patents. He organized the International Conference on Biomedical Engineering (ICBME-2011) as the main Chair (along with Dr. AG Ramakrishnan, IISc, Bangalore, and Dr. JK Udupa, UPenn, USA), and the IGSTC- sponsored Indo-German Symposium “Advances in Medical Technology towards Current Healthcare Necessities”, March 2014 (along with Dr. MMM Pai & Dr. Arved Huebler), both in Manipal, India.
Current interests of Dr. Galigekere include Biomedical Signal processing, and medical imaging/Image Processing: contact/non-contact methods of estimation & analysis of vitals in humans and animal models (with specific attention to zebrafish larvae), analysis of naadi signals, image processing and visualization in microscopy and nuclear medicine. He is a Senior Member of the IEEE, and a Life Member of the Biomedical Engineering Society of India.